Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women
Assess the relationship between age and breast cancer-specific survival among older women and determine whether the observed age-related disparities in survival is explained by differences in breast cancer treatments received.
Women ≥65 years old at diagnosis with stage I–IIIA breast cancer diagnosed between 1997 and 1998 were recruited from four regions of the United States and followed prospectively for 5 years after diagnosis. Data was obtained from tumor registries, medical records, and telephone interviews. The primary endpoint was breast cancer-specific survival. Our independent variables were age operationalized as ≤75 years vs. >75 years, and receipt of recommended guideline therapy, adapted from the National Institutes of Health guideline consensus conference.
Of 689 women, 36% were >75 years. Women >75 years were less likely to have received the following; axillary lymph node dissection (84% vs. 93%, P = 0.0003), radiotherapy (40% vs. 54%, P = 0.0003), definitive primary therapy (71% vs. 84%, P < 0.0001), chemotherapy (9% vs. 28%, P < 0.0001), and guideline therapy (31% vs. 54%, P < 0.0001). The 5-year breast cancer-specific survival was 95% (95% confidence interval [CI], 90%, 97%) for those ≤75 years who received guideline therapy, 94% (95% CI, 90%, 97%) for those ≤75 years who did not receive guideline therapy, 96% (95% CI, 88%, 99%) for those >75 years who received guideline therapy and 83% (95% CI, 74%, 89%) for those >75 years who did not receive guideline therapy, (P = 0.002) by the log-rank test.
Receipt of guideline therapy may reduce the age-related disparity in breast cancer survival among older women.
KeywordsBreast cancer Older women Patterns␣of␣care Breast cancer-specific survival Undertreatment
Unable to display preview. Download preview PDF.
- 2.Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Jr., Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst 93(13):979–989PubMedCrossRefGoogle Scholar
- 3.NIH Consensus Development Conference statement on the treatment of earlystage breast cancer (1991) Oncology (Williston Park) 5(2):120–124Google Scholar
- 5.Surveillance, Epidermiology and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality -All COD, Public-Use With State, Total U.S. (1969–2002), National Cancer Institue, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005. Underlying mortality data provided by NCHS (www.cdc.gov/nchs)Google Scholar
- 10.Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R (2000) Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 89(3):561–573PubMedCrossRefGoogle Scholar
- 15.Du X, Freeman JL, Freeman DH, Syblik DA, Goodwin JS (1999) Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995. J Gerontol A Biol Sci Med Sci 54(9):M474–M478Google Scholar
- 25.Greene FL, Page DL, Fleming ID, et al (eds) (2002) AJCC (American Joint Commitee on Cancer) Cancer staging manual. Springer-Verlag, New York, Pp. 223–240Google Scholar
- 27.National Comprehensive Cancer Network. Clinical Practice Guidelines in Breast Cancer. Version 1.2006Google Scholar
- 28.Ware J (1993) SF-36 health survey: manual and interpretation guide. The Health Institute, Boston, MAGoogle Scholar
- 30.Wanebo HJ, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, Bland K (1997) Is surgical management compromised in elderly patients with breast cancer? Ann Surg 225(5):579–586; discussion 586–9Google Scholar